Sorrento Therapeutics (NASDAQ:SRNE) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance SRNE stock opened at $0.14 on Thursday. Sorrento Therapeutics has a 1 year low of $0.16 and a 1 year high […]